Statin use vs. average non-HDL cholesterol levels in Bahrain

Bahrain: Statin use vs. average non-HDL cholesterol levels was 3.3 in 2018. ▼ Falling

Latest (2018)
3.3
Change on year
unchanged
World rank
95th
of 191 countries
All-time high
3.9
in 1980
All-time low
3.3
in 2017
Years of data
39
1980–2018

Statin use vs. average non-HDL cholesterol levels in Bahrain, 1980–2018

012341980199920181980: 3.91981: 3.91982: 3.91983: 3.91984: 3.91985: 3.91986: 3.91987: 3.91988: 3.91989: 3.91990: 3.91991: 3.91992: 3.91993: 3.91994: 3.91995: 3.91996: 3.91997: 3.81998: 3.81999: 3.82000: 3.82001: 3.82002: 3.82003: 3.72004: 3.72005: 3.72006: 3.72007: 3.62008: 3.62009: 3.62010: 3.62011: 3.52012: 3.52013: 3.52014: 3.42015: 3.42016: 3.42017: 3.32018: 3.3

Source: World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data.

Analysis

Bahrain recorded 3.3 for statin use vs. average non-hdl cholesterol levels in 2018. That is the lowest value across all 39 years on record.

That represents a change of down 8.3% over ten years.

Over the whole period, statin use vs. average non-hdl cholesterol levels in Bahrain peaked at 3.9 in 1980 and was at its lowest, 3.3, in 2017.

That places Bahrain 95th out of 191 countries with data for 2018, putting it in the middle of the range.

The long-run direction has been consistently falling across the 39 years of available data.

Statin use vs. average non-HDL cholesterol levels in Bahrain, year by year

Annual values for Statin use vs. average non-HDL cholesterol levels in Bahrain, 1980 to 2018.
Year Value Change
1980 3.9
1981 3.9 +0.0%
1982 3.9 +0.0%
1983 3.9 +0.0%
1984 3.9 +0.0%
1985 3.9 +0.0%
1986 3.9 +0.0%
1987 3.9 +0.0%
1988 3.9 +0.0%
1989 3.9 +0.0%
1990 3.9 +0.0%
1991 3.9 +0.0%
1992 3.9 +0.0%
1993 3.9 +0.0%
1994 3.9 +0.0%
1995 3.9 +0.0%
1996 3.9 +0.0%
1997 3.8 -2.6%
1998 3.8 +0.0%
1999 3.8 +0.0%
2000 3.8 +0.0%
2001 3.8 +0.0%
2002 3.8 +0.0%
2003 3.7 -2.6%
2004 3.7 +0.0%
2005 3.7 +0.0%
2006 3.7 +0.0%
2007 3.6 -2.7%
2008 3.6 +0.0%
2009 3.6 +0.0%
2010 3.6 +0.0%
2011 3.5 -2.8%
2012 3.5 +0.0%
2013 3.5 +0.0%
2014 3.4 -2.9%
2015 3.4 +0.0%
2016 3.4 +0.0%
2017 3.3 -2.9%
2018 3.3 +0.0%

Bahrain compared with similar countries

  • Bahrain's 3.3 is below the median for high income countries, which is 3.5, 94% of the median. (61 countries reporting)
  • Bahrain's 3.3 is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 3.35, 99% of the median. (22 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
1980s 3.9 3.9 3.9 10
1990s 3.87 3.8 3.9 10
2000s 3.7 3.6 3.8 10
2010s 3.43 3.3 3.6 9

Countries ranked near Bahrain

  1. 95 Algeria 3.3 compare
  2. 95 Azerbaijan 3.3 compare
  3. 95 Barbados 3.3 compare
  4. 95 Bolivia 3.3 compare
  5. 95 Bosnia and Herzegovina 3.3 compare
  6. 95 Cambodia 3.3 compare
  7. 95 China 3.3 compare
  8. 95 Cuba 3.3 compare
  9. 95 Egypt 3.3 compare
  10. 95 Ghana 3.3 compare
  11. 95 Kiribati 3.3 compare
  12. 95 Laos 3.3 compare
  13. 95 Luxembourg 3.3 compare
  14. 95 Marshall Islands 3.3 compare
  15. 95 Netherlands 3.3 compare
  16. 95 Spain 3.3 compare
  17. 95 Sri Lanka 3.3 compare
  18. 95 Suriname 3.3 compare
  19. 95 Turkey 3.3 compare
  20. 95 Turkmenistan 3.3 compare
  21. 95 United Kingdom 3.3 compare
  22. 95 United States 3.3 compare

See the full ranking of 191 places →

More reference data data for Bahrain

All data for Bahrain →

Frequently asked questions

What is statin use vs. average non-hdl cholesterol levels in Bahrain?
Statin use vs. average non-hdl cholesterol levels in Bahrain was 3.3 in 2018, according to World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data.
What is the highest statin use vs. average non-hdl cholesterol levels recorded in Bahrain?
The highest recorded value was 3.9 in 1980.
What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Bahrain?
The lowest recorded value was 3.3 in 2017.
How does Bahrain rank for statin use vs. average non-hdl cholesterol levels?
Bahrain ranks 95th out of 191 countries with data for 2018.
Is statin use vs. average non-hdl cholesterol levels rising or falling in Bahrain?
Over the last ten years it is down 8.3%. The long-run trend across the full record is falling.
Where does this Bahrain data come from?
The figures come from World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Statin use vs. average non-HDL cholesterol levels in Bahrain. Statizoid, drawing on World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data. Retrieved 23 September 2026, from https://reference.statizoid.com/stat/statin-use-vs-average-non-hdl-cholesterol-levels/bahrain/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/statin-use-vs-average-non-hdl-cholesterol-levels/bahrain/">Statin use vs. average non-HDL cholesterol levels in Bahrain</a> — Statizoid

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.